1. Gangjee A, Adair OO, Pagley M, Queener SF.
N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase.
J Med Chem. 2008 Oct 9;51(19):6195-200. Epub 2008 Sep 5.
PMID: 18771252 [PubMed - in process]
2. Bolstad DB, Bolstad ES, Frey KM, Wright DL, Anderson AC.
Structure-Based Approach to the Development of Potent and Selective Inhibitors of Dihydrofolate Reductase from Cryptosporidium.
J Med Chem. 2008 Oct 4. [Epub ahead of print]
PMID: 18834108 [PubMed - as supplied by publisher]
3. Strobl JS, Seibert CW, Li Y, Nagarkatti R, Mitchell SM, Rosypal AC, Rathore D, Lindsay DS.
Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active anti-proliferative and tumor cell differentiation agent.
J Parasitol. 2008 Oct 6:1. [Epub ahead of print]
PMID: 18837587 [PubMed - as supplied by publisher]
4. Gangjee A, Adair OO, Pagley M, Queener SF.
N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase.
J Med Chem. 2008 Oct 9;51(19):6195-200. Epub 2008 Sep 5.
PMID: 18771252 [PubMed - in process]
Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine.
Int J Antimicrob Agents. 2008 Oct;32(4):360-2. Epub 2008 Jul 10.
PMID: 18619816 [PubMed - in process]
6. [“borderline” article]
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
Drug Discov Today. 2008 Oct 4. [Epub ahead of print]
PMID: 18840542 [PubMed - as supplied by publisher]
7. Cho Y, Ioerger TR, Sacchettini JC.
Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening.
J Med Chem. 2008 Oct 9;51(19):5984-92. Epub 2008 Sep 9.
PMID: 18778048 [PubMed - in process]
8. Cosconati S, Hong JA, Novellino E, Carroll KS, Goodsell DS, Olson AJ.
Structure-Based Virtual Screening and Biological Evaluation of Mycobacterium tuberculosis Adenosine 5'-Phosphosulfate Reductase Inhibitors.
J Med Chem. 2008 Oct 15. [Epub ahead of print]
PMID: 18855373 [PubMed - as supplied by publisher]
9. Mao J, Eoh H, He R, Wang Y, Wan B, Franzblau SG, Crick DC, Kozikowski AP.
Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase.
Bioorg Med Chem Lett. 2008 Oct 1;18(19):5320-3. Epub 2008 Aug 14.
PMID: 18783951 [PubMed - in process]
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
J Antimicrob Chemother. 2008 Nov;62(5):1037-45. Epub 2008 Aug 7.
PMID: 18693235 [PubMed - in process]
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
J Antimicrob Chemother. 2008 Oct;62(4):713-9. Epub 2008 Jun 27.
PMID: 18587134 [PubMed - in process]
CoMFA based de novo design of pyrrolidine carboxamides as inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
J Mol Model. 2008 Oct;14(10):923-35. Epub 2008 Jul 15.
PMID: 18626672 [PubMed - in process]
13. Pietka-Ottlik M, Wójtowicz-Młochowska H, Kołodziejczyk K, Piasecki E, Młochowski J.
New Organoselenium Compounds Active against Pathogenic Bacteria, Fungi and Viruses.
Chem Pharm Bull (Tokyo). 2008 Oct;56(10):1423-7.
PMID: 18827382 [PubMed - in process]
14. Lamani DS, Venugopala Reddy KR, Bhojya Naik HS, Savyasachi A, Naik HR.
Synthesis and DNA binding studies of novel heterocyclic substituted quinoline schiff bases: a potent antimicrobial agent.
Nucleosides Nucleotides Nucleic Acids. 2008 Oct;27(10):1197-210.
PMID: 18788049 [PubMed - in process]